Berlot Giorgio, Di Bella Stefano, Tomasini Ariella, Roman-Pognuz Erik
Azienda Sanitaria Universitaria Giuliano-Isontina, Department of Anesthesia and Intensive Care Medicine, Cattinara University Hospital, 34100 Trieste, Italy.
Clinical Department of Medical, Surgical and Health Sciences, Infectious Diseases Unit, Trieste University Hospital, 34100 Trieste, Italy.
Antibiotics (Basel). 2022 Jan 29;11(2):180. doi: 10.3390/antibiotics11020180.
The extracorporeal elimination of a pathogen or damage-associated molecular pattern via blood purification techniques is increasingly being used in patients with septic shock and other clinical conditions characterized by a life-threatening inflammatory response. The removal of these substances can be accomoplished by means of ultrafiltration or hemoadsorption. Independently from the blood putification technique used, they could also affect the clearance of antibacterial and antifungal agents with a potentially significant clinical impact. In our review, we describe the basic principles of ultrafiltration and hemoadsorption, the available devices for this latter and the existing experimental and clinical studies; the final paragraph is dedicated to practical considerations that can help clinicians to consider the clearance of antibiotics and antifungals attributable to these techniques to minimize the risk of a iatrogenic underdosage.
通过血液净化技术对病原体或损伤相关分子模式进行体外清除,越来越多地应用于脓毒性休克患者以及其他以危及生命的炎症反应为特征的临床病症。这些物质的清除可通过超滤或血液吸附来实现。无论采用何种血液净化技术,它们都可能影响抗菌和抗真菌药物的清除,具有潜在的重大临床影响。在我们的综述中,我们描述了超滤和血液吸附的基本原理、用于后者的现有设备以及现有的实验和临床研究;最后一段专门讨论了一些实际考量因素,这些因素可帮助临床医生考虑这些技术导致的抗生素和抗真菌药物清除情况,以尽量降低医源性用药不足的风险。